For: | Nesti L, Trico D. Cardioprotective effects of glucagon-like peptide 1 receptor agonists in heart failure: Myth or truth? World J Diabetes 2024; 15(5): 818-822 [PMID: 38766425 DOI: 10.4239/wjd.v15.i5.818] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v15/i5/818.htm |
Number | Citing Articles |
1 |
Filippo Biondi, Rosalinda Madonna. The Potential Role of GLP1-RAs Against Anticancer-Drug Cardiotoxicity: A Scoping Review. Journal of Clinical Medicine 2025; 14(8): 2705 doi: 10.3390/jcm14082705
|
2 |
Nicola Riccardo Pugliese, Francesco Paneni, Domenico Tricò, Alessandra Violet Bacca, Nicolò De Biase, Hermann Dalpiaz, Alessandro Mengozzi, Agostino Virdis, Lorenzo Ghiadoni, Stefano Taddei, Reinhold Kreutz, Konstantinos Tsioufis, Stefano Masi. Refining the link between obesity and heart failure: insights from GLP-1 receptor agonist trials and studies adopting direct adiposity measures. Cardiovascular Diabetology 2025; 24(1) doi: 10.1186/s12933-025-02778-6
|
3 |
Ashkan Hashemi, Min Ji Kwak, Parag Goyal. Pharmacologic Management of Heart Failure with Preserved Ejection Fraction (HFpEF) in Older Adults. Drugs & Aging 2025; 42(2): 95 doi: 10.1007/s40266-024-01165-2
|
4 |
Paulo César Gete Palacios, Alberto Moscona-Nissan, Renata Saucedo, Aldo Ferreira-Hermosillo. Impact on Metabolism Generated by Surgical and Pharmacological Interventions for Weight Loss in Women with Infertility. Metabolites 2025; 15(4): 260 doi: 10.3390/metabo15040260
|